This Personalized Crispr Therapy Is Designed to Attack Tumors
Nov 14, 2022•6 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In a small study, researchers modified patients’ immune cells to target their particular cancer—but it only worked for a third of volunteers.
Learn about your ad choices: dovetail.prx.org/ad-choices
For the best experience, listen in Metacast app for iOS or Android